VTE risk higher with newer oral contraceptives

USERS of newer oral contraceptives have almost double the risk of venous thromboembolism (VTE) compared to those taking pills with older progestins, a large UK study has found. 

University of Nottingham researchers found that women taking pills with the new generation progestins had a four times higher risk and users of older pills had a 2.5 times higher risk of developing VTE compared to non-users. 

This makes pills containing drospirenone, desogestrel, gestodene and cyproterone 1.5 to 1.8 times more likely to result in VTE compared to older pills containing levonorgestrel, norethisterone and norgestimate